Leeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL.
Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
Prev Sci. 2024 Oct;25(7):1065-1078. doi: 10.1007/s11121-024-01711-9. Epub 2024 Jul 26.
Adjuvant endocrine therapy (AET) reduces mortality in early-stage breast cancer, but adherence is low. We developed a multicomponent intervention to support AET adherence comprising: text messages, information leaflet, acceptance and commitment therapy (ACT), and side-effect website. Guided by the multiphase optimization strategy, the intervention components were tested in the ROSETA pilot optimization trial. Our mixed-methods process evaluation investigated component acceptability. The pilot optimization trial used a 2 fractional factorial design. Fifty-two women prescribed AET were randomized to one of eight experimental conditions, containing unique component combinations. An acceptability questionnaire was administered 4 months post-randomization, and semi-structured interviews with 20 participants further explored acceptability. Assessments were guided by four constructs of the theoretical framework of acceptability: affective attitude, burden, perceived effectiveness, and coherence. Quantitative and qualitative findings were triangulated to identify agreements/disagreements. There were high overall acceptability scores (median = 14-15/20, range = 11-20). There was agreement between the qualitative and quantitative findings when triangulated. Most participants "liked" or "strongly liked" all components and reported they required low effort to engage in. Between 50% (leaflet) and 65% (SMS) "agreed" or "strongly agreed," it was clear how each component would help adherence. Perceived effectiveness was mixed, with 35.0% (text messages) to 55.6% (ACT) of participants "agreeing" or "strongly agreeing" that each component would improve their adherence. Interview data provided suggestions for improvements. The four components were acceptable to women with breast cancer and will be refined. Mixed-methods and triangulation were useful methodological approaches and could be applied in other optimization trial process evaluations.
辅助内分泌治疗(AET)可降低早期乳腺癌的死亡率,但患者的依从性较低。我们开发了一种多组分干预措施来支持 AET 依从性,包括:短信、信息传单、接受和承诺疗法(ACT)以及副作用网站。该干预措施以多阶段优化策略为指导,在 ROSETA 先导优化试验中进行了测试。我们的混合方法过程评估调查了组成部分的可接受性。该先导优化试验使用了 2 分数阶析因设计。52 名接受 AET 治疗的女性被随机分配到 8 个实验组中的一个,每个实验组包含独特的组件组合。在随机分组后 4 个月进行了可接受性问卷评估,并对 20 名参与者进行了半结构化访谈,进一步探讨了可接受性。评估受可接受性理论框架的四个构建体的指导:情感态度、负担、感知有效性和一致性。定量和定性发现被三角剖分以确定一致/不一致之处。总体可接受性评分较高(中位数为 14-15/20,范围为 11-20)。当三角剖分时,定性和定量发现之间存在一致性。大多数参与者“喜欢”或“非常喜欢”所有组件,并报告说他们只需要很少的努力就能参与。在 50%(传单)至 65%(短信)的参与者“同意”或“强烈同意”之间,清楚地表明每个组件将如何帮助他们坚持治疗。感知有效性参差不齐,35.0%(短信)至 55.6%(ACT)的参与者“同意”或“强烈同意”每个组件都将提高他们的依从性。访谈数据提供了改进建议。四项组成部分均被乳腺癌女性接受,并将进一步改进。混合方法和三角剖分是有用的方法学方法,可应用于其他优化试验过程评估。